Close Menu

NEW YORK (GenomeWeb) – Bio-Techne announced today that it has agreed to acquire Advanced Cell Diagnostics for $250 million in cash, plus an additional consideration of $75 million if certain milestones are achieved.

The deal is expected to close on or about August 1, and will be financed through a combination of cash on hand and a revolving line of credit facility that Bio-Techne said it expects to obtain. The company expects the acquisition to be slightly dilutive to its adjusted earnings per share for fiscal year 2017, and accretive thereafter.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.